| SC 13D/A | 2024-03-13 | Meyer Thomas | Altamira Therapeutics Ltd. | 22,297 | 1.2% | EDGAR |
| SC 13D/A | 2023-04-27 | Meyer Thomas | Altamira Therapeutics Ltd. | 88,603 | 1.3% | EDGAR |
| SC 13D/A | 2023-01-18 | Meyer Thomas | Altamira Therapeutics Ltd. | 84,106 | 6.3% | EDGAR |
| SC 13D/A | 2022-09-13 | Meyer Thomas | Altamira Therapeutics Ltd. | 1,677,152 | 8.0% | EDGAR |
| SC 13D/A | 2022-05-13 | Meyer Thomas | Altamira Therapeutics Ltd. | 1,163,639 | 7.4% | EDGAR |
| SC 13D/A | 2021-05-21 | Meyer Thomas | Auris Medical Holding Ltd. | 817,263 | 6.3% | EDGAR |
| SC 13G/A | 2021-02-12 | Altium Capital Management LP | Auris Medical Holding Ltd. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2020-12-07 | Meyer Thomas | Auris Medical Holding Ltd. | 660,525 | 5.7% | EDGAR |
| SC 13D/A | 2020-10-06 | Meyer Thomas | Auris Medical Holding Ltd. | 660,525 | 9.2% | EDGAR |
| SC 13D/A | 2020-08-20 | Meyer Thomas | Auris Medical Holding Ltd. | 532,912 | 8.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Altium Capital Management LP | Auris Medical Holding Ltd. | 897,435 | 9.9% | EDGAR |
| SC 13D/A | 2019-08-12 | Meyer Thomas | Auris Medical Holding Ltd. | 529,573 | 15.4% | EDGAR |
| SC 13D/A | 2019-06-13 | Meyer Thomas | Auris Medical Holding Ltd. | 489,573 | 14.4% | EDGAR |
| SC 13G | 2019-05-23 | Altium Capital Management LP | Auris Medical Holding Ltd. | 220,000 | 9.9% | EDGAR |
| SC 13G/A | 2019-02-15 | Rosalind Advisors, Inc. | Auris Medical Holding AG | 420,000 | 1.2% | EDGAR |
| SC 13D/A | 2019-02-14 | Sofinnova Capital VII FCPR | Auris Medical Holding AG | 331,147 | 0.9% | EDGAR |
| SC 13D/A | 2018-11-21 | Meyer Thomas | Auris Medical Holding AG | 9,165,947 | 27.1% | EDGAR |
| SC 13G | 2018-08-10 | Rosalind Advisors, Inc. | Auris Medical Holding AG | 2,050,489 | 8.3% | EDGAR |
| SC 13G/A | 2018-08-09 | MORGAN STANLEY | Auris Medical Holding AG | 261,426 | 1.0% | EDGAR |
| SC 13D/A | 2018-07-23 | Meyer Thomas | Auris Medical Holding AG | 5,869,083 | 24.4% | EDGAR |